To evaluate and recommend novel therapies aimed at reducing cardiovascular risk in patients with type 2 diabetes.
Consensus-based decision pathway developed by a panel of experts in diabetes and cardiovascular disease.
Review of current literature on interventions available for cardiovascular risk reduction in type 2 diabetes.
Evaluation of various therapeutic strategies for effectiveness and applicability.
Identified multiple novel therapies that significantly lower cardiovascular risk in patients with type 2 diabetes.
Highlighted the need for personalized treatment plans based on patient characteristics and preferences.
Recommended ongoing monitoring and adjustment of cardiovascular risk interventions in clinical practice.
Abstract
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.